Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 8, 2003, Pages 657-665

  Grünert, Stefan ^a   Jechlinger, Martin ^b   Beug, Hartmut ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; COLLAGEN GEL; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; RAS PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UVOMORULIN; VIMENTIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; CANCER INVASION; CELL CULTURE; CELL PROLIFERATION; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM METASTASIS; PHENOTYPE; RAS PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0043172396     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1175     Document Type: Review

References (54)

1. Hunter, T. Oncoprotein networks. Cell 88, 333-346 (1997).
2. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
3. Elenbaas, B. & Weinberg, R. A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 264, 169-184 (2001).
4. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
5. Cordon-Cardo, C. & Prives, C. At the crossroads of inflammation and tumorigenesis. J. Exp. Med. 190, 1367-1370 (1999).
6. Hay, E. D. An overview of epithelio-mesenchymal transition. Acta Anat. 154, 8-20 (1995).
7. Viebahn, C. Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo. Acta Anat. 154, 79-97 (1995).
8. Sun, D., Baur, S. & Hay, E. D. Epithelial-mesenchymal transformation is the mechanism for fusion of the craniofacial primordia involved in morphogenesis of the chicken lip. Dev. Biol. 228, 337-349 (2000).
9. Martinez-Alvarez, C. et al. Medial edge epithelial cell fate during palatal fusion. Dev. Biol. 220, 343-357 (2000).
10. Duband, J. L., Monier, F., Delannet, M. & Newgreen, D. Epithelium-mesenchyme transition during neural crest development. Acta Anat. 154, 63-78 (1995).
11. Knight, D. Epithelium-fibroblast interactions in response to airway inflammation. Immunol. Cell Biol. 79, 160-164 (2001).
12. Alpers, C. E. et al. Localization of SPARC in developing, mature, and chronically injured human allograft kidneys. Kidney Int. 62, 2073-2086 (2002).
13. Yang, J. & Liu, Y. Blockage of tubular epithelia] to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13, 96-107 (2002).
14. Petersen, O. W. et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162, 391-402 (2003).
15. Putz, E. et al. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res 59, 241-248 (1999).
16. Brabletz, T. et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc. Natl Acad. Sci. USA 98, 10356-10361 (2001).
17. Oft, M., Heider, K. H. & Beug, H. TGFβ signalling is essential for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, 1243-1252 (1998).
18. Janda, E. et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313 (2002).
19. Fialka, J. et al. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol. 132, 1115-1132 (1996).
20. Oft, M. et al. TGFβ1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477 (1996).
21. Janda, E., Litos, G., Grunert, S., Downward, J. & Beug, H. Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene 21, 5148-5159 (2002).
22. Lehmann, K. et al. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14, 2610-2622 (2000).
23. Gotzmann, J. et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J. Cell Sci. 115, 1189-1202 (2002).
24. Miettinen, P. J., Ebner, R., Lopez, A. R. & Derynck, R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021-2036 (1994).
25. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C. H. & ten Dijke, P. TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112, 4557-4568 (1999).
26. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. A. & Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810 (2000).
27. Bhowmick, N. A. et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27-36 (2001).
28. Sun, D., Vanderburg, C. R., Odierna, G. S. & Hay, E. D. TGFβ3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development 125, 95-105 (1998).
29. Cui, W. et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542 (1996).
30. Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet. 29, 117-129 (2001).
31. Ten Diike, P., Goumans, M. J., Itoh, F. & Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191, 1-16 (2002).
32. Attisano, L. & Wrana, J. L. Signal transduction by the TGF-β superfamily. Science 296, 1646-1647 (2002).
33. Heldin, C. H. & Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316 (1999).
34. Schulze, A., Lehmann, K., Jefferies, H. B., McMahon, M. & Downward, J. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15, 981-994 (2001).
35. Beddington, R. S. & Robertson, E. J. Axis development and early asymmetry in mammals. Cell 96, 195-209 (1999).
36. Ciruna, B. & Rossant, J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1, 37-49 (2001).
37. Vicovac, L. & Aplin, J. D. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat. 156, 202-216 (1996).
38. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R. & Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115 (1988).
39. Muraoka, R. S. et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551-1559 (2002).
40. Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262-267 (1998).
41. Eger, A., Stockinger, A., Schaffhauser, B., Beug, H. & Foisner, R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of β-catenin and upregulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell Biol. 148, 173-188 (2000).
42. Stockinger, A., Eger, A., Wolf, J., Beug, H. & Foisner, R. E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity. J. Cell Biol. 154, 1185-1196 (2001).
43. Labbe, E., Letamendia, A. & Attisano, L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and wnt pathways. Proc. Natl Acad. Sci. USA 97, 8358-8363 (2000).
44. Pradet-Balade, B., Boulme, F., Beug, H., Mullner E. W. & Garcia-Sanzl J. A. Translation control: bridging the gap between genomics and proteomics? Trends Biochem. Sci. 26, 225-229 (2001).
45. Vecsey-Semjen, B. et al. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene 21, 4646-4662 (2002).
46. Andrechek, E. R. et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl Acad. Sci. USA 97, 3444-3449 (2000).
47. Webster, M. A. et al. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell Biol. 18, 2344-2359 (1998).
48. Weeks, B. H., He, W., Olson, K. L. & Wang, X. J. Inducible expression of transforming growth factor β1 in papillomas causes rapid metastasis. Cancer Res. 61, 7435-7443 (2001).
49. Oft, M., Akhurst, R. J. & Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biol. 4, 487-494 (2002).
50. Jacob, S. & Praz, F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 84, 27-47 (2002).
51. Takaku, K. et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656 (1998).
52. McEarchern, J. A. et al. Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int. J. Cancer 91, 76-82 (2001).
53. Yang, Y. A. et al. Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest. 109, 1607-1615 (2002).
54. Jechlinger, M. et al. Expression profiling of epithelial plasticity in tumour progression Oncogene (in the press).